Poland· PL-100194797
Claritine Active
A loratadine product containing loratadinum + pseudoephedrini sulfas, registered in Poland by Bayer Sp. z o.o.. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Loratadine is registered in 18 of 19 countries.
Countries holding a registration under ATC R06AX13 (loratadine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Loratadine · ATC R06AX13
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of loratadine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.18 in France to $0.57 in Switzerland — a ×3.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Loratadine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.57
- IT Italy$0.21
- FR France$0.18
The record
At a glance
URPL (Poland)- Active substance
- Loratadinum + Pseudoephedrini sulfas
- Manufacturer
- Bayer Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- R06AX13
- ATC class
- Loratadine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990706112
- gtin05909990886500
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
539 interactions on record for loratadine.
Graded by severity as the source publishes them — 74 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Loratadine · interactions on record
539 records
- 74 moderate
- 12 minor
- 453 info
Most severe, free to view
- TroglitazoneA10BG01moderate
- Glycerol phenylbutyrateA16AX09moderate
- LonafarnibA16AX20moderate
- FostamatinibB02BX09moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Loratadine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaCLARITIN ALLERGY + SINUSBAYER INC
- United StatesClaritin-DBayer HealthCare LLC.
- CzechiaCLARINASE REPETABSBAYER s.r.o., Praha
- SpainCLARITYNE PLUS 10mg/240mg COMPRIMIDOS DE LIBERACION PROLONGADABayer Hispania S.L.
- FinlandClarinaseSchering-Plough Europe
- IcelandClarinaseBayer AB
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Clarinase
- Belgium · Clarinase Once Daily, Clarinase Repetabs
- Bulgaria · Клариназе
- Cyprus · Clarityne-D
- Czechia · Clarinase Repetabs
- Denmark · Clarinase
- Spain · Clarityne Plus, Narine Repetabs
- Greece · Clarityne-D
- Croatia · Clarinase
- Iceland · Clarinase
- Malta · Clarinase Repetabs
- Portugal · Claridon
- Romania · Clarinase
- Slovenia · Claritine Kombo
- Slovakia · Clarinase Repetabs
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5cf95ccd-fa49-4e8c-9fd5-f2c8f7ac4359 GET /v1/drugs/5cf95ccd-fa49-4e8c-9fd5-f2c8f7ac4359?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki o przedłużonym uwalnianiu",
"source": "urpl",
"strength": "5 mg + 120 mg",
"packaging": "05909990706112 ¦ OTC ¦ Skasowane ¦ 11307\n10 tabl.\n05909990886500 ¦ OTC ¦ 68022\n6 tabl.",
"substance": "Loratadinum 5 mg + Pseudoephedrini sulfas 120 mg",
"common_name": "Loratadinum + Pseudoephedrini sulfas",
"pl_product_id": "100194797",
"pozwolenie_nr": "07061",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about loratadine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.